prednisone has been researched along with tegafur in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Hamaguchi, M; Hara, K; Inden, Y; Kitayama, J; Kobayashi, R; Kobori, O; Ohi, T; Osada, T; Tomiyama, J; Tsukui, G | 1 |
Chin, K; Furuta, N; Hatake, K; Itoh, Y; Mishima, Y; Mizunuma, N; Nagasaki, E; Shinozaki, E; Takahashi, S; Terui, Y; Tokutome, N; Usui, N | 1 |
Cheng, SX; Peng, T; Su, J; Zhuo, RX | 2 |
5 other study(ies) available for prednisone and tegafur
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[A carcinoma of the right breast arising after a mastectomy in primary malignant lymphoma of the left breast].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Lymphoma; Mastectomy, Modified Radical; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Tegafur; Vincristine | 1989 |
[Simultaneous detection of both non-Hodgkin's lymphoma cells and breast cancer cells in pleural effusion--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Combinations; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pleural Effusion; Prednisone; Tamoxifen; Tegafur; Uracil; Vincristine | 2003 |
Poly-alpha,beta-(N-(2-hydroxyethyl)-L-aspartamide)-g-poly(1,3trimethylene carbonate) amphiphilic graft co-polymer as a potential drug carrier.
Topics: Biocompatible Materials; Dioxanes; Drug Carriers; Drug Delivery Systems; In Vitro Techniques; Magnetic Resonance Spectroscopy; Materials Testing; Nanostructures; Peptides; Polymers; Prednisone; Spectroscopy, Fourier Transform Infrared; Surface-Active Agents; Tegafur | 2006 |
Degradation and drug release properties of poly-alpha,beta-[N-(2-hydroxyethyl)-L-aspartamide]-g-poly(2,2-dimethyltrimethylene carbonate).
Topics: Biocompatible Materials; Delayed-Action Preparations; Drug Delivery Systems; Microscopy, Electron, Transmission; Nanoparticles; Peptides; Polymers; Prednisone; Solubility; Tegafur; Water | 2007 |